Angelo Moesslang

Angelo Moesslang brings over 20 years of leadership experience and a proven track record as a finance and healthcare executive in the medical device industry. He will closely work together with Ron Stubbers, MBA, who will continue leading the company’s operational activities.

With his valuable expertise in the medical device industry, his understanding of the US and European healthcare systems as well as his experience in negotiating strategic partnerships and entering markets overseas, Angelo is a perfect fit for guiding InGeneron through the next stage of development, said Eckhard Alt, MD, PhD, Chairman of the Board of InGeneron. He is an excellent addition to the company and will help to further establish a leading position in the field of regenerative medicine.

Prior to joining InGeneron, Angelo Moesslang was CFO of Fresenius Medical Care North America Holdings, Inc., the US-based division of Fresenius Medical Care, a global medical device and healthcare services group. Earlier roles in his career include CFO for Fresenius Medical Care Europe, Africa, Middle East & Latin America, Vice President for Business Development for Fresenius Medical Care Asia Pacific, and Head of Investor Relations for Fresenius Medical Care. Angelo Moesslang holds a Doctorate in Business Administration from the University of Hohenheim and a Master’s Degree in Economics from the Ludwig-Maximilian University of Munich.